GLOBAL PHARMACEUTICAL MARKET TRENDS: OPPORTUNITIES FOR DEVELOPMENT
Abstract
Global medicine spending will reach nearly $1.12 trillion by 2022 on an invoice price basis, up nearly $370 billion from the 2016 estimated spending level. Current trends are based on disruptive technologies including gene-editing, precision medicines and digital technologies, Big Data etc. The characteristics of biopharmaceutical innovation have also evolved over the past two decades, with increases in the share of cancer treatment launch, orphan indications.
About the Authors
D. A. Demidyonok
St. Petersburg State Chemical and Pharmaceutical Academy of the Ministry of Healthcare
Russian Federation
Russian Federation
T. A. Petrova
St. Petersburg State Chemical and Pharmaceutical Academy of the Ministry of Healthcare
Russian Federation
Russian Federation
I. A. Narkevich
St. Petersburg State Chemical and Pharmaceutical Academy of the Ministry of Healthcare
Russian Federation
Russian Federation
V. A. Markova
St. Petersburg State Chemical and Pharmaceutical Academy of the Ministry of Healthcare
Russian Federation
Russian Federation
References
1. JC. Scheeren. New approaches of regulating innovative medicines. Industry perspectives on regulating innovative medicines // 6th FIP Pharmaceutical Sciences World Congress, 2017. Швеция, Стокгольм.
2. Lifetime Trends in Biopharmaceutical Innovation // QuintilesIMS Institute. URL: http://www.imshealth.com/en/thought-leadership/quintilesims-institute/reports/lifetime-trends-in-biopharmaceutical-innovation (дата обращения 26.07.2017).
3. L. Liberti. Exploring Innovative Regulatory Pathways: A US Perspective // 6th FIP Pharmaceutical Sciences World Congress, 2017. Швеция, Стокгольм.
4. HC. Mahler. Biologics Drug Product Development & Manufacture: Current Challenges & Innovation // 6th FIP Pharmaceutical Sciences World Congress, 2017. Швеция, Стокгольм.
5. Personalized Medicine Coalition. Personalized Medicine at FDA, 2016. Progress Report.
6. T. Salmonson. Future medicines: regulatory sciences // 6th FIP Pharmaceutical Sciences World Congress, 2017. Швеция, Стокгольм.
7. Д.А. Демидёнок, В.А. Маркова. Перспективы использования метода 3D-печати для производства термолабильных лекарственных препаратов // Сборник материалов IV Всероссийской научно-практической конференции с международным участием «Инновации в здоровье нации». Санкт-Петербургская государственная химико-фармацевтическая академия. - Санкт-Петербург. 2016. С. 294-298.
8. European Medicines Agency. Identifying opportunities for «big data» in medicines development and regulatory science. Report from a workshop held by EMA on 14-15 November 2016. Р. 3-9.
9. А. Cave. Opportunities and Challenges for Big Data to Support Regulatory Decision Making // 6th FIP Pharmaceutical Sciences World Congress, 2017. Швеция, Стокгольм.
10. Т. Allvin. The Innovative pipelines of the pharmaceutical industry // 6th FIP Pharmaceutical Sciences World Congress, 2017. Швеция, Стокгольм.
11. А.А. Сёмин. Анализ отечественного и зарубежного опыта по планированию и регулированию исследований в области фармацевтики // Кубанский научный медицинский вестник. 2017. № 3(24). C. 149-159.
Review
For citations:
Demidyonok D.A., Petrova T.A., Narkevich I.A., Markova V.A. GLOBAL PHARMACEUTICAL MARKET TRENDS: OPPORTUNITIES FOR DEVELOPMENT. Drug development & registration. 2017;(4):282-287. (In Russ.)
Views:
1128
Email this article 